DL-Glyceraldehyde 3-phosphate
Names
[ CAS No. ]:
591-59-3
[ Name ]:
DL-Glyceraldehyde 3-phosphate
[Synonym ]:
dl-glyceraldehyde 3-phosphate
Biological Activity
[Description]:
[Related Catalog]:
[In Vitro]
[In Vivo]
[References]
Chemical & Physical Properties
[ Density]:
1.721g/cm3
[ Boiling Point ]:
399.2ºC at 760mmHg
[ Molecular Formula ]:
C3H7O6P
[ Molecular Weight ]:
170.05800
[ Flash Point ]:
195.2ºC
[ Exact Mass ]:
169.99800
[ PSA ]:
113.87000
MSDS
Safety Information
[ Symbol ]:
GHS05
[ Signal Word ]:
Danger
[ Hazard Statements ]:
H314
[ Precautionary Statements ]:
P280-P305 + P351 + P338-P310
[ Personal Protective Equipment ]:
Faceshields;full-face respirator (US);Gloves;Goggles;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter
[ Risk Phrases ]:
34
[ Safety Phrases ]:
26-27-36/37/39-45
[ RIDADR ]:
UN 1760 8/PG 2
[ Packaging Group ]:
II
Articles
J. Surg. Res. 194(2) , 571-80, (2015)
High-mobility group box 1 (HMGB1) has recently been identified as an important mediator of various kinds of acute and chronic inflammation. The protein encoded by the box-A domain of the HMGB1 gene is...
MicroRNA-33a regulates cholesterol synthesis and cholesterol efflux-related genes in osteoarthritic chondrocytes.Arthritis. Res. Ther. 17 , 42, (2015)
Several studies have shown that osteoarthritis (OA) is strongly associated with metabolism-related disorders, highlighting OA as the fifth component of the metabolic syndrome (MetS). On the basis of o...
Intraplacental gene therapy with Ad-IGF-1 corrects naturally occurring rabbit model of intrauterine growth restriction.Hum. Gene Ther. 26(3) , 172-82, (2015)
Intrauterine growth restriction (IUGR) due to placental insufficiency is a leading cause of perinatal complications for which there is no effective prenatal therapy. We have previously demonstrated th...